首页> 外文期刊>The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology >Modeling and Simulation Analysis of the Relationship Between Lesion Recurrence on Brain Images and Clinical Recurrence in Patients With Ischemic Stroke
【24h】

Modeling and Simulation Analysis of the Relationship Between Lesion Recurrence on Brain Images and Clinical Recurrence in Patients With Ischemic Stroke

机译:缺血性脑卒中患者脑图像病变复发与临床复发关系的建模与仿真分析

获取原文
获取原文并翻译 | 示例
       

摘要

The objective of current study is to assess the relationship between characteristics of patients with acute ischemic stroke and clinical recurrences to identify predictors for the prognosis by modeling and simulation. Primary endpoint was clinical recurrence of ischemic stroke, and secondary endpoint was occurrence of any of the following clinical recurrence of ischemic stroke, transient ischemic attack, acute coronary syndrome, or vascular deaths. Time to event models were developed by NONMEM (R) using prospectively collected clinical data from 270 patients over 5 years, where 7.0% and 9.3% of them experienced lesion recurrence on MRI at 1 month (LR1M) and clinical recurrence, respectively. Exponential models best described the data. LR1M and diabetes mellitus history were significant predictors for primary endpoint. Times to recurrence for patients with LRIM (+) and diabetes mellitus (+) were predicted to be 0.095 and 0.317 of those for patients with LRIM (-) and diabetes mellitus (-), respectively. LR1M was only predictor for secondary endpoint with predicted time to recurrence in patients with LR1M (+) compared to 0.141 of LR1M (-). Quantitative prediction of clinical recurrence using MRI could improve personalized therapy by identifying patients at risk of recurrence, and could enable efficient clinical trials by stratifying the patients.
机译:当前研究的目的是评估急性缺血性中风患者的特征与临床复发之间的关系,以通过建模和模拟来确定预后的预测因子。主要终点是缺血性中风的临床复发,次要终点是以下任何缺血性中风,短暂性脑缺血发作,急性冠状动脉综合征或血管性死亡的临床复发。事件发生时间模型是由NONMEM(R)使用前瞻性收集的5年中270例患者的临床数据开发的,其中7.0%和9.3%的患者分别在1个月时MRI复发(LR1M)和临床复发。指数模型最能描述数据。 LR1M和糖尿病史是主要终点的重要预测指标。预测LRIM(+)和糖尿病(+)患者的复发时间分别为LRIM(-)和糖尿病(-)患者的0.095和0.317。 LR1M仅是次要终点的预测指标,与LR1M(-)的0.141(-)相比,LR1M(+)的患者预计可复发。使用MRI对临床复发的定量预测可以通过识别有复发风险的患者来改善个性化治疗,并可以通过对患者进行分层来进行有效的临床试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号